Press Releases

Press Releases

LEXINGTON, MA – March 4, 2015 Quanterix Corporation, a leader in ultrasensitive single molecule measurement for the benefit of human health, today announced the appointment of Kevin Hrusovsky as Chief Executive Officer (“CEO”). Mr. Hrusovsky will continue to serve as Executive Chairman of its Board…
LEXINGTON, MA – July 17, 2015 Quanterix Corporation, a leader in high definition diagnostics, delivering ultrasensitive single molecule measurement for the benefit of human health, today announced that it will be presenting at The Alzheimer’s Association International Conference (AAIC), July 18-23…
LEXINGTON, MA – November 17, 2015 Quanterix Corporation, a leader in high definition diagnostics, delivering ultrasensitive single molecule measurement for the benefit of human health, today announced that the paper, “
March 1, 2016
Quanterix announces that it has been selected by Fast Company as one of the world’s top 10 most innovative companies in 2016 in Sports – the only medical technology company to be recognized in this category.
September 26, 2016
Quanterix announces that it is making a strategic investment in ImmunArray, a molecular diagnostics company advancing the development of novel, multi-marker tests for complex diseases with compelling levels of accuracy.
Discussion to be led by Cedars-Sinai Medical Center Professor of Medicine Dr. Jennifer E. Van Eyk
Quanterix is sponsoring a webinar by Dr. Jennifer E. Van Eyk, professor of medicine, Cedars-Sinai Medical Center, on the need for precise protein quantification and identification in personalized medicine on Tuesday, April 18, 2017 from 1:00 – 2:00 p.m. EST.
July 18, 2017
Dr. Daniel Sikkema joins Quanterix as Vice President of Accelerator Services to lead the growth of the company’s contract research lab and support precision health advances across a wide range of therapeutic categories
CAMBRIDGE, MA – December 1, 2010 – Quanterix Corporation announced today that Martin D. Madaus, Ph.D has joined the company’s Board as Executive Chairman. Dr. Madaus brings more than 20 years of experience in the diagnostics and life science industries, most recently serving as President, Chairman…
CAMBRIDGE, MA – August 19, 2011 – Quanterix Corporation, a company enabling a new generation of molecular diagnostic tests based on its revolutionary Single Molecule Array (SiMoA™) technology, today announced results of a pilot study to measure biomarkers of inflammation from patients with Crohn’s…
LEXINGTON, MA – April 23, 2012 – Quanterix Corporation, the leading developer of high definition diagnostic tools based on its revolutionary Single Molecule Array (SiMoA™) technology, announced today that it has moved to a newly renovated facility in Lexington, MA to accommodate the company's…